In vitro studies of the 4F peptide in mouse and human primary glial cells demonstrated that 4F increases the lipidation of APOE, the primary apolipoprotein associated with HDL-like particles in the brain, and the greatest known genetic risk factor for AD. The gene discussed is APOE; the disease is Alzheimer disease.